You searched for bladder cancer | Page 3 of 33

Signatera MRD Test Gets Breakthrough Device Designations

Natera has received two new FDA Breakthrough Device Designations for its personalized Signatera ctDNA test.

Posted by Chris Wolski | Jun 19, 2025 | Cancer |

CAP has updated 23 cancer protocols to align with the latest standards from AJCC and WHO, enhancing diagnostic precision and patient care.

Posted by Chris Wolski | Jun 17, 2025 | Pancreatic |

ClearNote Health and University Hospital Southampton have launched the SAFE-D study to evaluate the Avantect Pancreatic Cancer Test.

Posted by Chris Wolski | Jun 4, 2025 | Cancer |

Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.

Posted by Chris Wolski | May 30, 2025 | Cytology |

AIxMed and Lumea have partnered to integrate AIxMed’s urine cytology diagnostic tool, AIxURO, into Lumea’s digital pathology platform.